Solazyme (SZYM +3.5%) reports Q1 revenue was $13.6M vs. $7.7M Y/Y; on a non-GAAP basis net loss...

|By:, SA News Editor

Solazyme (SZYM +3.5%) reports Q1 revenue was $13.6M vs. $7.7M Y/Y; on a non-GAAP basis net loss was $12.8M vs. a loss of $5.6M Y/Y. "We have a strong balance sheet with ~$219M in cash, cash equivalents and marketable securities, our partnerships continue to advance, and we are well positioned to continue commercializing our technology," CEO Tyler Painter says.